Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5401
Lionsgate Studios
LION
$3.53B
| $307K | ﹤0.01% |
41,059
+26,980
| +192% | +$211K |
|
5402
KVH Industries
KVHI
$141M
| $307K | ﹤0.01% |
57,949
+1,002
| +2% | +$5.71K |
|
|
NPB
5403
Northpointe Bancshares
NPB
$591M
| $306K | ﹤0.01% |
+21,172
| New | +$303K |
|
5404
Fidelity Enhanced International ETF
FENI
$11.3B
| $304K | ﹤0.01% |
10,218
+1,814
| +22% | +$53.4K |
|
5405
HUTCHMED
HCM
$2.17B
| $304K | ﹤0.01% |
20,196
-6,315
| -24% | -$93.4K |
|
5406
Blink Charging
BLNK
$85.5M
| $303K | ﹤0.01% |
330,401
-318,733
| -49% | -$369K |
|
5407
Sera Prognostics
SERA
$77.9M
| $303K | ﹤0.01% |
82,327
-99,145
| -55% | -$505K |
|
|
SPMC
5408
Sound Point Meridian Capital
SPMC
$222M
| $303K | ﹤0.01% |
15,188
+522
| +4% | +$10.9K |
|
5409
Caesarstone
CSTE
$104M
| $302K | ﹤0.01% |
124,424
+23,638
| +23% | +$88.5K |
|
|
DMF
5410
DELISTED
BNY Mellon Municipal Income
DMF
| $301K | ﹤0.01% |
41,909
-1,101
| -3% | -$7.9K |
|
5411
Westwood Holdings Group
WHG
$182M
| $301K | ﹤0.01% |
18,566
+9,250
| +99% | +$144K |
|
5412
A2Z Smart Technologies
AZ
$298M
| $301K | ﹤0.01% |
42,579
+41,979
| +6,997% | +$291K |
|
|
ADVM
5413
DELISTED
Adverum Biotechnologies
ADVM
| $300K | ﹤0.01% |
68,717
-46,071
| -40% | -$208K |
|
5414
Galectin Therapeutics
GALT
$316M
| $299K | ﹤0.01% |
245,092
-44,992
| -16% | -$63.1K |
|
5415
FT Vest Rising Dividend Achievers Target Income ETF
RDVI
$3.7B
| $298K | ﹤0.01% |
12,582
+2,599
| +26% | +$64.2K |
|
|
WSO.B
5416
Watsco Inc Class B
WSO.B
$13.6B
| $298K | ﹤0.01% |
588
| – | – |
|
|
BKCG
5417
BNY Mellon Concentrated Growth ETF
BKCG
$124M
| $298K | ﹤0.01% |
+9,641
| New | +$298K |
|
5418
CB Financial Services
CBFV
$193M
| $296K | ﹤0.01% |
10,400
+2,210
| +27% | +$63.5K |
|
5419
Lexicon Pharmaceuticals
LXRX
$1.08B
| $296K | ﹤0.01% |
641,629
+115,479
| +22% | +$72.9K |
|
|
HELP
5420
Cybin Inc
HELP
$625M
| $295K | ﹤0.01% |
46,526
+35,884
| +337% | +$311K |
|
5421
JPMorgan International Growth ETF
JIG
$500M
| $295K | ﹤0.01% |
4,648
-241
| -5% | -$15.6K |
|
|
KWY
5422
Kingsway Corp
KWY
$282M
| $294K | ﹤0.01% |
37,180
+6,166
| +20% | +$48.6K |
|
5423
Evotec
EVO
$746M
| $294K | ﹤0.01% |
88,041
-37,880
| -30% | -$155K |
|
5424
Lightwave Logic
LWLG
$1.16B
| $293K | ﹤0.01% |
285,867
-155,894
| -35% | -$243K |
|
5425
Lexeo Therapeutics
LXEO
$375M
| $293K | ﹤0.01% |
84,316
+9,488
| +13% | +$42K |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.